{"database": "lobbying", "table": "lobbying_activities", "rows": [[1728568, "8166c445-908e-4dec-bbb5-624b9f4d691b", "Q3", "STANTON PARK GROUP", 83717, "MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)", 2015, "third_quarter", "MMM", "Medicare, oncology, radiation and imaging reimbursement issues;  Medicare physician payments; application of the sequester to cancer drug reimbursement; prompt pay discount; Oncology payment disparities in Medicare\nHR 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)\nH.R.2895, the Medicare Patient Access to Cancer Treatment Act of 2015\nHR 6, the 21st Century Cures Act", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2015-10-12T15:44:21.037000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1728568"], "units": {}, "query_ms": 0.43192197335883975, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}